Sunitinib malate and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sunitinib malate (sunitinib malate) and Calcium (calcium). Common drug interactions include haemoglobin decreased among females and gastritis among males.

The phase IV clinical study analyzes what interactions people have when they take Sunitinib malate and Calcium. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

On Jul, 20, 2026

31 people who take Sunitinib malate and Calcium together, and have interactions are studied.

Sunitinib malate and Calcium drug interactions.

What are the common drug interactions of Sunitinib Malate and Calcium, by gender? *:

female:

Haemoglobin decreased
Hyperkalaemia (damage to or disease of the kidney)
Hypophagia (reduced food intake)
Influenza like illness
Insomnia (sleeplessness)
Leukopenia (less number of white blood cells in blood)
Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)
Neurological symptom (symptoms of nervous system disease)
Oral pain
Perirenal haematoma (haemorrhage from the kidney into the perirenal space)

male:

Gastritis (inflammation of stomach)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Malaise (a feeling of general discomfort or uneasiness)
Pain in extremity
Angiopathy (generic term for a disease of the blood vessels)
Asthenia (weakness)
Ataxia (loss of full control of bodily movements)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Diarrhoea
Disease recurrence

What are the common drug interactions of Sunitinib Malate and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abortion spontaneous (naturally occurring miscarriage)
Drug exposure during pregnancy
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

40-49:

Haemoglobin decreased
Perirenal haematoma (haemorrhage from the kidney into the perirenal space)
Upper respiratory tract infection
Viral infection

50-59:

Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Overdose
Dizziness
Fatigue (feeling of tiredness)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)
Nausea (feeling of having an urge to vomit)
Vitamin d decreased

60+:

Asthenia (weakness)
Fatigue (feeling of tiredness)
Alopecia (absence of hair from areas of the body)
Back pain
Blood pressure systolic increased
Body temperature decreased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Death
Depression
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 25.81%
Renal Cell Carcinoma (a kidney cancer): 7 people, 22.58%
Pain: 7 people, 22.58%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 16.13%
Diabetes: 4 people, 12.90%
Portal Hypertensive Gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;): 4 people, 12.90%
Gastritis Atrophic (process of chronic inflammation of the stomach mucosa): 4 people, 12.90%
Hepatic Neoplasm Malignant (liver cancer): 4 people, 12.90%
Nausea (feeling of having an urge to vomit): 4 people, 12.90%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Sunitinib malate and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously